|
2024 Conference Publication Assessment of precision melanoma diagnostics: Circulating microrna expression to monitor late-stage treatmentHarris, Teresa, Zaenker, Pauline, McEvoy, Ashleigh C., Soyer, H. Peter, Khattak, Muhammad A., Ziman, Melanie, Millward, Michael, Gray, Elin S. and Stark, Mitchell S. (2024). Assessment of precision melanoma diagnostics: Circulating microrna expression to monitor late-stage treatment. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-7626 |
|
2023 Conference Publication 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survivalZhou, C., Tan, S. X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D., Soyer, H., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2023). 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.279 |
|
2023 Conference Publication Automated photodamage assessment from 3D total body photography for an objective assessment of melanoma riskKahler, Sam, Rutjes, Chantal, Yan, Siyuan, Mothershaw, Adam, Yu, Zhen, Jayasinghe, Dilki, Ge, Zongyuan, Stark, Mitchell, Janda, Monika, Soyer, Peter and Betz-Stablein, Brigid (2023). Automated photodamage assessment from 3D total body photography for an objective assessment of melanoma risk. Australasian College of Dermatologists 55th Annual Scientific Meeting, Engage, Enhance, Elevate, Virtual, 27-29 May 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication 203 Automated skin surface phenotype for melanoma risk assessmentBetz-Stablein, B. D., Rutjes, C., Kahler, S., Mothershaw, A., Jayasinghe, D., Stark, M., Janda, M. and Soyer, H. (2023). 203 Automated skin surface phenotype for melanoma risk assessment. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.205 |
|
2023 Conference Publication Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent neviMuse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. 114th Annual Meeting of the American Association for Cancer Research (AACR), Orlando Fl, Apr 14-19, 2023. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2023-6000 |
|
2020 Conference Publication Identification of a novel microrna panel: potential biomarkers for non-small cell lung cancerKan, C., Crovetto, N., Landreneau, R., Li, L., Soyer, H., Stark, M. S. and Gunn, S. (2020). Identification of a novel microrna panel: potential biomarkers for non-small cell lung cancer. Southern Regional Meeting of the American-Federation-for-Medical-Research (AFMR), New Orleans, LA, United States, 13-15 February 2020. London, United Kingdom: B M J Group. doi: 10.1136/jim-2020-SRM.565 |
|
2018 Conference Publication Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanomaEmran, A., Marzese, D. M., Menon, D. R., Stark, M., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Hammerlindl, S., Gupta, D., Mills, G. B., Lu, Y., Flaherty, K., Sturm, R., Hoon, D. S. B., Gabrielli, B., Herlyn, M. and Schaider, H. (2018). Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia , 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.16_12815 |
|
2018 Conference Publication Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasmsStark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, Illinois, 14-18 April 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2018-5376 |
|
2017 Conference Publication The prevalence of BRAF and NRAS in dermoscopic subtypes of acquired naeviTan, J-M., Tom, L., Jagirdar, K., Lambie, D., Sturm, R., Soyer, P. and Stark, M. (2017). The prevalence of BRAF and NRAS in dermoscopic subtypes of acquired naevi. Australasian College of Dermatologists 50th Annual Scientific Meeting, Darling Harbour, New South Wales, Australia, 6–9 May 2017. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.21_12652 |
|
2016 Conference Publication Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma modelAhmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584 |
|
2016 Conference Publication Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?Stark, M., Gray, E., Ziman, M., Soyer, H. P. and Schaider, H. (2016). Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?. 16th World Congress on Cancers of the Skin , Vienna, Austria, 31 August - 3 September 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins. |
|
2016 Conference Publication Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancerEmran, A. A., Menon, D. R., Marzese, D., Hammerlindl, H., Brafford, P., Stark, M., Huang, S., Hammerlindl, S., Gupta, D., Soyer, P., Sturm, R., Hoon, D., Gabrielli, B., Herlyn, M. and Schaider, H. (2016). Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2013 Conference Publication Distinct profiles for lung cancer and its major subtypesWright, C. M., Francis, S. M. Savarimuthu, Sriram, K. B., Stark, M. S., Hayward, N. K., Yang, I. A., Bowman, R. V. and Fong, K. M. (2013). Distinct profiles for lung cancer and its major subtypes. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12045 |
|
2011 Conference Publication Mapping the lung cancer methylomeWright, C. M., Francis, S. M. S., Sriram, K. B., Quinn, K. R., Stark, M. S., Hayward, N. K., Yang, I. A., Bowman, R. V. and Fong, K. M. (2011). Mapping the lung cancer methylome. 3rd Australian Lung Cancer Conference (ALCC), Melbourne VIC, Australia, 6-9 October 2010. Philadelphia PA, United States: Lippincott Williams & Wilkins. |
|
2001 Conference Publication Mutation analysis of the CDKN2A promoter in Australian melanoma familiesPollock, Pamela. M., Stark, Mitchell, Palmer, Jane M., Walters, Marilyn K., Martin, Nick G., Green, Adele C. and Hayward, Nicholas K. (2001). Mutation analysis of the CDKN2A promoter in Australian melanoma families. Unknown, Unknown, Unknown. New York, NY, United States: Springer Nature. doi: 10.1038/87254 |
